Stock Events

Stock Events

BridgeBio Pharma (2CL.F) Q4 2024 Earnings

12NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.95

-0.69

-0.44

-0.19

Details

Expected EPS

-0.9450753900999999

Actual EPS

-0.8100769999999999

Surprise EPS

0.13

Surprise Percent

+14.28%

Description

BridgeBio Pharma (2CL.F) has reported earnings of -0.8100769999999999 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.